Patents Assigned to Compagnie de Developpment Aguettant S.A.
  • Method of treating HIV in humans by administration of ddI and hydroxycarbamide
    Patent number: 5736527
    Abstract: A method and composition for inhibiting the spread of a retrovirus such as HIV in a human cell population in which a retrovirus such as HIV is present has been found. The spread of the retrovirus is inhibited by treatment of the cells with a synergistic combination mixture of a dideoxy-ribonucleoside excluding AZT and hydroxycarbamide.
    Type: Grant
    Filed: March 18, 1996
    Date of Patent: April 7, 1998
    Assignee: Compagnie de Developpment Aguettant S.A.
    Inventors: Serge D. Malley, Jorge R. Vila
  • Method of treating HIV in humans by administration of ddI and hydroxycarbamide
    Patent number: 5521161
    Abstract: A method and composition for inhibiting the spread of a retrovirus such as HIV in a human cell population in which a retrovirus such as HIV is present has been found. The spread of the retrovirus is inhibited by treatment of the cells with a synergistic combination mixture of a dideoxy-ribonucleoside excluding AZT and hydroxycarbamide.
    Type: Grant
    Filed: December 20, 1993
    Date of Patent: May 28, 1996
    Assignee: Compagnie de Developpment Aguettant S.A.
    Inventors: Serge D. Malley, Jorge R. Vila